Navigation Links
Study Finds Heart Failure Drug Ineffective
Date:7/6/2011

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, July 6 (HealthDay News) -- The heart failure drug Natrecor (nesiritide) is ineffective and linked to increased rates of potentially dangerous low blood pressure, a new study finds.

The intravenous drug was approved in 2001 to help heart failure patients breathe more easily when they were struggling with severe shortness of breath. But the drug had no significant effect on breathing difficulties or other disease-related problems and may also result in low blood pressure, according to the researchers.

The report was published in the July 7 issue of the New England Journal of Medicine.

The study "doesn't show any use for nesiritide, that's for sure," said Dr. Eric J. Topol, professor of translational genomics at the Scripps Research Institute in La Jolla, Calif., and author of an accompanying journal editorial.

Topol noted nesiritide isn't used much, because it is considered no better than some other less expensive drugs. According to Topol, who was not involved in the study, nesiritide can cost $500 to $700 per infusion. Other drugs such as Lasix (furosemide),and nitroglycerin given intravenously cost substantially less and have proven efficacy, he said.

However, Topol's real concerns are much broader. "It shouldn't take this long to find out the truth about a drug," he said. "There should be a drive to get as much information about a drug as early as possible and not have a lost decade, as we saw here."

One of the study authors noted that the research documented the potential risks and benefits of the drug in people with heart failure who have severe trouble breathing -- a condition called dyspnea -- because their disease is worsening.

"This trial demonstrated that nesiritide did not cause an increase in the rate of death or worsening of renal function and that prior concerns regarding the safety of nesiritide were unfounded," said st
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. New study: Women less likely than men to fake soccer injuries
2. Long Commutes for Pilots May Hamper Flying Performance: Study
3. Study Finds Most Urgent Angioplasties Warranted
4. Mammogram Schedule Should Be Customized, Study Finds
5. Small, Rural Hospitals Provide a Lower Quality of Care: Study
6. Infants learn to transfer knowledge by 16 months, study finds
7. Massage Beats Meds for Lower Back Pain, Study Says
8. Radiation rates for breast cancer may be underestimated, U-M study finds
9. Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
10. Tots Who Are Late Talkers Typically Turn Out Fine: Study
11. Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Heart Failure Drug Ineffective
(Date:7/23/2014)... Lake Worth, FL (PRWEB) July 23, 2014 ... will take place Aug. 10-16, Millennium Treatment Group is ... Substance abuse has existed in society ever since man ... make wine. Substance abuse treatment has existed since shortly ... of recognizing a problem and then developing a way ...
(Date:7/23/2014)... July 23, 2014 A new study ... power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive ... throughout a woman’s body, Bernstein Liebhard LLP reports. The ... Journal of the American Medical Association, looked at 36,000 ... at 500 U.S. hospitals from 2006 to 2012. Ninety-nine ...
(Date:7/23/2014)... Alan Mozes HealthDay Reporter ... servicemen are more likely to have been exposed to some ... new survey suggests. The finding seems to apply solely ... that the finding could be a cause for concern, given ... and/or sexual abuse among the civilian population has been linked ...
(Date:7/23/2014)... YORK, NY, July 24, 2014) If past experience ... York State are about to get a lot more ... laws already on the books allowing NPs to provide ... to patient care and better relationships with physicians and ... a study from Columbia University School of Nursing, published ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:New York law offers nurses more recognition, responsibility 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
... has earmarked $74 million to combat the bird flu threat ... was to announce the funding in Busan, Korea, where he ... ,International agencies, like the World Health Organization (WHO), would ... would go on a simulation exercise run by APEC to ...
... to the World Health Organization (WHO) experts, concerted ... complete eradication of the five neglected tropical diseases ... // years. , WHO has identified five ... leishmaniasis (kala azar), soil transmitted helminths (STH) and ...
... the national nursing shortage by producing more qualified nursing ... Robert W. Woodruff Foundation has awarded // $995,000 to ... support its new doctorate of nursing practice program, the ... ,Thanking the Atlanta-based Woodruff Foundation, a private organization, for ...
... by the Italian phrase 'malaria' — or 'bad air' — ... days, scientists know malaria is spread by mosquitos. // And ... the spread of a disease that kills 1 million people ... the situation is bad. The number of deaths are rising, ...
... hospital will begin performing open-heart surgeries on patients in ... new unit equipped with the // latest equipment including ... light, automatic operation bed and latest x-ray machines for ... superintendent, IGMC., ,The new unit will be launched ...
... movie may induce enough stress to interfere with your ... you sit down to watch a violent or // ... ability. ,David Beversdorf, a neurologist at the State ... and asked them to combine movie viewing with problem-solving ...
Cached Medicine News:Health News:Concerted Effort Imperative For Elimination Of Tropical Diseases: WHO 2Health News:Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program 2Health News:Malaria Vaccine May Be 10 Years Away 2Health News:Malaria Vaccine May Be 10 Years Away 3
(Date:7/23/2014)... PLAINS, N.Y. , July 23, 2014 /PRNewswire-USNewswire/ ... approval of idelalisib to treat patients with relapsed ... small lymphocytic lymphoma (SLL) is a significant advance ... Idelalisib, which goes by the trade name ... a protein that is highly expressed in many ...
(Date:7/23/2014)... July 23, 2014  Varian Medical Systems (NYSE: ... $1.02 per diluted share in the third quarter of ... about $0.06 per diluted share due to an approximately ... Varian,s existing equity investment in Augmenix, a privately-held company ... totaled $748 million for the third quarter of fiscal ...
(Date:7/23/2014)... Conn. , July 23, 2014 UBM ... – a new online community and information resource ... better manage and treat their patients with neurological ... coupled with an aging population, necessitates greater access to ... disorders.  Key statistics on neurological conditions include: ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3
... Rochester Medical Implants ( http://www.rmi.us.com ), a contract manufacturer ... it has relocated corporate offices and manufacturing operations to ... the location change, the company will change its name ... The new facility is a modern 33,000-square ...
... Calif., Oct. 17, 2011 ChemoCentryx, Inc., today ... trial for CCX168, an orally-administered small molecule for ... (AAV), a disease which can lead to renal ... receptor (C5aR), a potent pro-inflammatory mediator that is ...
Cached Medicine Technology:Rochester Medical Implants Relocates to New Facility in Noblesville, IN 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 3ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 4
... CO2 laser system used in neurophysiology for studying ... the amplitude and/or the duration of the stimulus ... the laser emission in an ongoing manner by ... this laser include the high repeatability of the ...
... advanced system for laser therapy available today. The ... fiber handpiece that allows to perform linear scanning ... 20% of the energy reflected by the skin. ... special gel which optimizes the optical coupling between ...
Smart Chill is a compact cooling system that provides intense localised skin cooling through a comfortable contact handpiece....
... Smart 1064 DW with the capability of ... nm) offering increased coagulative and ablative capacities.Smart 1064 ... between two different wavelengths: ordinary 1064 nm (with ... 1320 nm (with powers among 2 and 25 ...
Medicine Products: